Sirio Pharma Co., Ltd (SIRIO®) today announces that SIRIO® has already completed acquisitions of Ayanda GmbH & Co. KG (Ayanda), a well-known softgel manufacturer in Europe. Ayanda has become a wholly-owned company of SIRIO®.
Founded in 1992, Ayanda is one of the Top-5 softgel manufacturers in Europe. With excellent production management system , cutting-edge product development capability, and specialized in complex formulations manufacturing , Ayanda has a good reputation and market share in the European dietary supplements industry.
Ayanda’s good reputation and production capacity in Europe will help SIRIO® to establish a global development and production service system. At the same time, Ayanda will also benefit from the multi-dosage form production capacity of SIRIO®, creating more values for customers in the European market. SIRIO® and Ayanda will work together to integrate our collective production, service and products. Together we complement each other’s advantages, and create much better values for customers.
We look forward to SIRIO® and Ayanda will provide high quality and innovative products to global customers more efficiently.
Founded in 1993, Sirio Pharma Co., Ltd (SIRIO®) is one of the main dietary supplement CDMOs, located in China, specialized in developing and manufacturing quality products including softgel, capsule, tablet, powder, gummy ,oral liquid, probiotics and other dosage forms. SIRIO® has been devoted to offer one-stop solutions including product developing, manufacturing, packaging and logistics to its customers.
Sirio is approved by TGA-GMP, NPA/UL GMP, BRC、UL’s Management System 21 CFR Part 111、ISO 9001:2015 certification, and etc. Cooperating with many well-known dietary supplement companies, Sirio is dedicated to provide products and service to customers all around the world.
For more information, please visit Sirio’s website at: www.siriopharm.com